Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects
Clinical trial NCT02256488 · COMPLETED
Trial details
- NCT number
- NCT02256488
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 1561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.